These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3070027)

  • 1. Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis.
    Pruzanski W; Vadas P
    J Rheumatol; 1988 Nov; 15(11):1601-3. PubMed ID: 3070027
    [No Abstract]   [Full Text] [Related]  

  • 2. Synovial fluid phospholipase A2s and inflammation.
    Gonzalez-Buritica H; Khamashita MA; Hughes GR
    Ann Rheum Dis; 1989 Apr; 48(4):267-9. PubMed ID: 2653242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.
    Pruzanski W; Scott K; Smith G; Rajkovic I; Stefanski E; Vadas P
    Inflammation; 1992 Oct; 16(5):451-7. PubMed ID: 1428121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of soluble and cell associated phospholipase A2 from rheumatoid synovial fluid.
    Gonzalez-Buritica H; Smith DM; Turner RA
    Ann Rheum Dis; 1989 Jul; 48(7):557-64. PubMed ID: 2774696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of phospholipase A2 activity in human synovial fluid by cations.
    Fawzy AA; Dobrow R; Franson RC
    Inflammation; 1987 Dec; 11(4):389-400. PubMed ID: 3692575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase activity in synovial fluid from patients with rheumatoid arthritis, osteoarthritis and crystal-associated arthritis.
    Loeser RF; Smith DM; Turner RA
    Clin Exp Rheumatol; 1990; 8(4):379-86. PubMed ID: 2118848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.
    Vadas P; Stefanski E; Pruzanski W
    Life Sci; 1985 Feb; 36(6):579-87. PubMed ID: 3918225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2.
    Murakami M; Kudo I; Nakamura H; Yokoyama Y; Mori H; Inoue K
    FEBS Lett; 1990 Jul; 268(1):113-6. PubMed ID: 2384146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.
    Pruzanski W; Vadas P; Stefanski E; Urowitz MB
    J Rheumatol; 1985 Apr; 12(2):211-6. PubMed ID: 4032400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.
    Vadas P; Stefanski E; Pruzanski W
    Inflammation; 1986 Jun; 10(2):183-93. PubMed ID: 3710562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of soluble phospholipase A2 from rheumatoid synovial fluid.
    Gonzalez-Buritica H; Smith DM; Turner RA
    Agents Actions; 1989 Jun; 27(3-4):477-80. PubMed ID: 2508447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in phospholipid composition of synovial fluid in children with various types of arthritis].
    Rakhimov MM; Pen'kova LIu; Iakubov IT
    Vopr Med Khim; 1995; 41(2):51-4. PubMed ID: 7793099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmental heterogeneity of soluble phospholipases A.
    Vadas P; Pruzanski W; Stefanski E; Sternby B
    Inflammation; 1990 Apr; 14(2):173-83. PubMed ID: 2323810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational modification of human synovial fluid phospholipase A2 inhibitors.
    Pisabarro MT; Ortiz AR; Palomer A; Cabré F; García L; Wade RC; Gago F; Mauleón D; Carganico G
    J Med Chem; 1994 Feb; 37(3):337-41. PubMed ID: 8308860
    [No Abstract]   [Full Text] [Related]  

  • 15. Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis.
    Kramer RM; Pepinsky RB
    Methods Enzymol; 1991; 197():373-81. PubMed ID: 2051933
    [No Abstract]   [Full Text] [Related]  

  • 16. Phospholipase A2 activity associated with synovial fluid cells.
    Pruzanski W; Vadas P; Kim J; Jacobs H; Stefanski E
    J Rheumatol; 1988; 15(5):791-4. PubMed ID: 3050083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against human synovial phospholipase A2.
    Takayama K; Kudo I; Hara S; Murakami M; Matsuta K; Miyamoto T; Inoue K
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1309-15. PubMed ID: 2322277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2.
    Marshall LA; Bauer J; Sung ML; Chang JY
    J Rheumatol; 1991 Jan; 18(1):59-65. PubMed ID: 2023201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple forms of phospholipase A2 in arthritic synovial fluid.
    Seilhamer JJ; Plant S; Pruzanski W; Schilling J; Stefanski E; Vadas P; Johnson LK
    J Biochem; 1989 Jul; 106(1):38-42. PubMed ID: 2777750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid assay of phospholipase A2 activity in plasma and synovial fluid.
    Gurakar-Osborne A; Prete PE
    Clin Chem; 1995 Jan; 41(1):118-9. PubMed ID: 7813061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.